ROIVANT SCIENCES LTD. (ROIV) /

The cash flow of ROIVANT SCIENCES LTD. over the past 6 years

Chart ROIVANT SCIENCES LTD.: operating cash flow, capital expenditures, free cash flow, fiscal 2021–2026 Open the chart →

In fiscal 2026, the latest fiscal year on file, ROIVANT SCIENCES LTD.'s operating cash flow was -$750.35M and its capital expenditures $8.21M, leaving free cash flow of -$758.56M. Free cash flow was below zero in all 6 years shown. It ranged from -$856.08M in fiscal 2023 to -$557.94M in fiscal 2021. Capital expenditures were highest in fiscal 2022, at $17.44M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2026ended Mar 31, 2026-$750.35M$8.21M-$758.56M
2025ended Mar 31, 2025-$839.45M$4.6M-$844.05M
2024ended Mar 31, 2024-$765.27M$1.38M-$766.65M
2023ended Mar 31, 2023-$843.39M$12.69M-$856.08M
2022ended Mar 31, 2022-$677.73M$17.44M-$695.16M
2021ended Mar 31, 2021-$552.14M$5.81M-$557.94M

Fiscal years as ROIVANT SCIENCES LTD. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ROIVANT SCIENCES LTD.

Companies of a similar size

Not investment advice. This page shows what ROIVANT SCIENCES LTD. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.